Franco-Nevada Corporation
FNVFranco-Nevada Corporation is coiled. The quarters are improving, yet the P/E sits at the 29th percentile of its own 5-year range — the business is moving before the market.
The sharpest disagreement: annual EPS moved +100.7% against a +21.3% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (7 weeks in) while the P/E sits at the 29th percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +40.0% year on year, and 141% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Franco-Nevada Corporation trades at $259, in a confirmed uptrend and 7 weeks into that stage. That is +10.4% against its own 200-day average. It sits at 77% of a 52-week range of $187 to $281. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 5 straight weeks.
Today the stock is in a confirmed uptrend — week 7 of stage 2. At $259 it trades +10.4% versus its 200-day average and sits at 77% of its 52-week range ($187–$281).
Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved +227% while the S&P 500 moved +255% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 5 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Franco-Nevada Corporation trades at 34.0× P/E, near the bottom of its own range — cheaper only 29% of the time. Its long-run median P/E is 38.9×, measured across 4.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 34.0× is near the bottom of its own range — cheaper only 29% of the time, against a long-run median of 38.9× measured over 4.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
Why the multiple sits where it does: over the past year annual EPS moved +100.7% against a +21.3% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +21.7%/yr price move, ~+30.4%/yr came from earnings growth and ~−8.7 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Franco-Nevada Corporation reads as improving on its fundamental arc. Improving — profit growth bottomed 7 quarters ago at −187.5% and has held its recovery at +87.3%, ROCE lifting at 23.2%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +64.0% | +11.3% | — | — |
| Profit | +101.8% | +16.6% | — | — |
| EPS | +100.7% | +16.4% | — | — |
| Stock price | +21.3% | +21.7% | +13.8% | +14.0% |
4-Factor Sector Score
57.2/100 — rank 10 of 28 in Gold · 85% evidence confidence
Franco-Nevada Corporation scores 57.2 out of 100 against the 28 companies it is compared with in Gold, ranking 10. Price leads the evidence: RS versus the benchmark is 6.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
The four contributions add to the total exactly: 16.4 + 12.3 + 11.8 + 16.7 = 57.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Franco-Nevada Corporation reported $0.6 B of revenue in the Jun 26 quarter, +56.8% year on year. That is the 7th straight quarter of year-on-year growth. Over 4 years it has compounded at 8.8% a year. The last full year, FY25, came in at $1.8 B. The last four reported quarters add to $2.3 B.
FY25 revenue came in at $1.8 B (+64.0% on the year), capping 4 years at 8.8% compound. The latest quarter (Jun 26) printed $0.6 B, +56.8% year on year — the 7th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +73.8% growth against the decade's 8.8% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +73.1% over the last 4 quarters against +43.3%/yr over the last 8 — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Franco-Nevada Corporation's operating margin is 77.6% in the Jun 26 quarter, −6.2 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged −35.2% to 74.2%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 77.6%, −6.2 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −35.2%–74.2%, and FY25's 74.2% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −6.2 pp year on year while gross margin went +4.6 pp — the loss came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Franco-Nevada Corporation earned $0.3 B of net profit in the Jun 26 quarter, +40.0% year on year. It is the 6th consecutive quarter of growth. Full-year FY25 profit was $1.1 B. The 4-year compound rate is 11.0%. That is 60.3% of the quarter's revenue. The same quarter a year earlier earned $0.3 B.
Jun 26 profit was $0.3 B, +40.0% year on year — the 6th consecutive quarter of growth. On the full year, FY25 printed $1.1 B (+101.8%), and the 4-year compound rate is 11.0%.
Why profit moved: revenue contributed +56.8% and the margin −6.2 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +90.7% vs revenue +73.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 141% of Franco-Nevada Corporation's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $1.5 B of operating cash against $1.1 B of profit. After $0.0 B of capital spending, $1.5 B was left as free cash.
FY25: operating cash of $1.5 B against reported profit of $1.1 B, leaving free cash of $1.5 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 141% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Franco-Nevada Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Franco-Nevada Corporation earns a ROE of 15% in FY25. That is up from a trough of −8% in FY23. Return on invested capital clears the cost of that capital by +9.3 percentage points, so growth here adds value rather than only size. The wiring behind it is 61.0% net margin on 0.22× asset turns.
FY25 ROE is 15%, recovered from a FY23 trough of −8% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 61.0% net margin × 0.22× asset turns × 1.08× balance-sheet leverage ≈ 14.5% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 18.8% − 9.5% = a +9.3 pp spread. The 9.5% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Franco-Nevada Corporation paid $1.64 per share over the last four reported quarters. The most recent declaration was $0.44 for Jun 26. Against the current price of $259 that is a trailing yield of 0.63%, measured on dividends already paid rather than on a forecast.
Franco-Nevada Corporation paid $1.64 per share across the last four reported quarters, most recently $0.44 for Jun 26. Against the current price of $259 the trailing twelve months work out to 0.63% — trailing dividends measured against today's price, not a forward estimate.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Franco-Nevada Corporation carries total debt of $0.0 B against shareholder equity of $8.2 B as of Jun 26, a debt-to-equity of 0.00 — effectively unlevered. On the annual view that ratio went from 0.00 in FY21 to 0.00 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.
Jun 26: total debt of $0.0 B against shareholder equity of $8.2 B — a debt-to-equity of 0.00. On the annual view, debt-to-equity went from 0.00 (FY21) to 0.00 (FY25). The returns on this page are earned, not borrowed.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
1.8% of Franco-Nevada Corporation's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 5.3 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 1.8% of the float is sold short, and at typical trading volumes it would take about 5.3 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Franco-Nevada Corporation: the Z-score reads 38.02. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 38.02 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 38.02.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Aura Minerals Inc.AUGO | 68.8/100Favorable setup74% evidence | BREAKING OUT | 23.6/35 Revenue 83.2% · PAT — · OPM change 12.5 pp 62% evidence | 17.9/25 ROCE 20.8% · OPM 53.7% 76% evidence | 7.9/20 P/E 75.6× · PEG 1.56 65% evidence | 19.4/20 RS sector 29.1% · RS bench 26.7% · 1Y 169%5 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 17.9 + 7.9 + 19.4 = 68.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Fortuna Mining Corp.FSM | 67.9/100Favorable setup71% evidence | BREAKING OUT | 25.4/35 Revenue 50.1% · PAT 100% · OPM change 23.9 pp 83% evidence | 13.2/25 ROCE 8.8% · OPM 52.6% 76% evidence | 11.0/20 P/E 9.4× · PEG — 15% evidence | 18.3/20 RS sector 8.8% · RS bench 8.7% · 1Y 40.8%6 of 12 weeks ahead 100% evidence |
| Exact sum: 25.4 + 13.2 + 11 + 18.3 = 67.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Wheaton Precious Metals Corp.WPM | 66.8/100Favorable setup85% evidence | BREAKING OUT | 24.9/35 Revenue 90.8% · PAT 100% · OPM change 6.3 pp 95% evidence | 14.0/25 ROCE 6.8% · OPM 71.8% 76% evidence | 9.5/20 P/E 24.9× · PEG 1.36 65% evidence | 18.4/20 RS sector 9.3% · RS bench 8.9% · 1Y 36.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 24.9 + 14 + 9.5 + 18.4 = 66.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4IAMGOLD CorporationIAG | 66.7/100Favorable setup81% evidence | BREAKING OUT | 24.7/35 Revenue 92.3% · PAT 47.3% · OPM change 29.2 pp 83% evidence | 13.0/25 ROCE 10.5% · OPM 52.9% 76% evidence | 14.7/20 P/E 10.9× · PEG 0.46 65% evidence | 14.3/20 RS sector 7.7% · RS bench 6.8% · 1Y 71.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 24.7 + 13 + 14.7 + 14.3 = 66.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5B2Gold Corp.BTG | 63.4/100Mixed-positive evidence74% evidence | BREAKING OUT | 23.1/35 Revenue 86.9% · PAT — · OPM change 9.8 pp 62% evidence | 14.0/25 ROCE 12.4% · OPM 49% 76% evidence | 12.0/20 P/E 12.6× · PEG 0.97 65% evidence | 14.3/20 RS sector 1.1% · RS bench 1.5% · 1Y 14.5%5 of 12 weeks ahead 100% evidence |
| Exact sum: 23.1 + 14 + 12 + 14.3 = 63.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Agnico Eagle Mines LimitedAEM | 59.8/100Mixed-positive evidence85% evidence | BREAKING OUT | 19.4/35 Revenue 50.3% · PAT 98.4% · OPM change 6.6 pp 95% evidence | 13.8/25 ROCE 6.9% · OPM 60.1% 76% evidence | 14.4/20 P/E 13.3× · PEG 0.42 65% evidence | 12.2/20 RS sector -0.1% · RS bench -0.5% · 1Y 21.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 13.8 + 14.4 + 12.2 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Royal Gold, Inc.RGLD | 59.0/100Thin evidence · provisional53% evidence | BREAKING OUT | 19.8/35 Revenue 70.7% · PAT 60.4% · OPM change — 45% evidence | 14.3/25 ROCE — · OPM — 15% evidence | 12.3/20 P/E 30.3× · PEG 0.78 65% evidence | 12.6/20 RS sector 0.4% · RS bench -0.1% · 1Y 28.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 14.3 + 12.3 + 12.6 = 59 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8AngloGold Ashanti plcAU | 58.5/100Mixed-positive evidence75% evidence | BREAKING OUT | 21.3/35 Revenue 54.6% · PAT 100% · OPM change 8.9 pp 95% evidence | 14.8/25 ROCE 11.8% · OPM 50.8% 76% evidence | 10.7/20 P/E 10.8× · PEG — 15% evidence | 11.7/20 RS sector 2.5% · RS bench 1.9% · 1Y 47.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 14.8 + 10.7 + 11.7 = 58.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9OceanaGold CorporationOGC | 58.2/100Mixed-positive evidence71% evidence | TURNING | 19.9/35 Revenue 62.5% · PAT 35.8% · OPM change -8.1 pp 83% evidence | 21.9/25 ROCE 42.7% · OPM 152.9% 76% evidence | 11.2/20 P/E 9× · PEG — 15% evidence | 5.2/20 RS sector -7.7% · RS bench -8.6% · 1Y 41.6%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19.9 + 21.9 + 11.2 + 5.2 = 58.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Franco-Nevada Corporationthis pageFNV | 57.2/100Mixed-positive evidence85% evidence | BREAKING OUT | 16.4/35 Revenue 73.7% · PAT 88.4% · OPM change -6.1 pp 95% evidence | 12.3/25 ROCE 5.7% · OPM 76.7% 76% evidence | 11.8/20 P/E 27.2× · PEG 0.9 65% evidence | 16.7/20 RS sector 5.9% · RS bench 6.1% · 1Y 21.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 12.3 + 11.8 + 16.7 = 57.2 · Decision use: Price leads the evidence: RS versus the benchmark is 6.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 11SSR Mining Inc.SSRM | 55.1/100Mixed-positive evidence81% evidence | BREAKING OUT | 25.0/35 Revenue 75.7% · PAT 100% · OPM change 17.9 pp 83% evidence | 8.4/25 ROCE 4.7% · OPM 51.6% 76% evidence | 6.3/20 P/E 28× · PEG 2.09 65% evidence | 15.4/20 RS sector 19.7% · RS bench 20.2% · 1Y 54.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 25 + 8.4 + 6.3 + 15.4 = 55.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Centerra Gold Inc.CGAU | 54.9/100Thin evidence · provisional58% evidence | BREAKING OUT | 17.7/35 Revenue — · PAT — · OPM change 8.1 pp 45% evidence | 7.3/25 ROCE 5.2% · OPM 22.4% 76% evidence | 11.4/20 P/E 4.9× · PEG — 15% evidence | 18.5/20 RS sector 24.5% · RS bench 23.9% · 1Y 129.8%7 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 7.3 + 11.4 + 18.5 = 54.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Aris Mining CorporationARIS | 54.1/100Thin evidence · provisional58% evidence | BREAKING OUT | 19.6/35 Revenue — · PAT — · OPM change 16.5 pp 45% evidence | 11.9/25 ROCE 7.7% · OPM 54.8% 76% evidence | 10.8/20 P/E 10.8× · PEG — 15% evidence | 11.8/20 RS sector 6% · RS bench 4.7% · 1Y 91.7%5 of 12 weeks ahead 100% evidence |
| Exact sum: 19.6 + 11.9 + 10.8 + 11.8 = 54.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Eldorado Gold CorporationEGO | 53.8/100Thin evidence · provisional58% evidence | BREAKING OUT | 17.1/35 Revenue — · PAT — · OPM change 19.2 pp 45% evidence | 8.1/25 ROCE 2.8% · OPM 51.4% 76% evidence | 10.3/20 P/E 11.1× · PEG — 15% evidence | 18.3/20 RS sector 9.6% · RS bench 9% · 1Y 45.4%7 of 12 weeks ahead 100% evidence |
| Exact sum: 17.1 + 8.1 + 10.3 + 18.3 = 53.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Newmont CorporationNEM | 53.1/100Mixed-positive evidence85% evidence | BREAKING OUT | 10.5/35 Revenue 25.2% · PAT 33.9% · OPM change -7.1 pp 95% evidence | 11.0/25 ROCE 6% · OPM 50.6% 76% evidence | 15.1/20 P/E 11.8× · PEG 0.28 65% evidence | 16.5/20 RS sector 8.3% · RS bench 8.1% · 1Y 49%5 of 12 weeks ahead 100% evidence |
| Exact sum: 10.5 + 11 + 15.1 + 16.5 = 53.1 · Decision use: Price leads the evidence: RS versus the benchmark is 8.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16Orla Mining Ltd.ORLA | 52.6/100Mixed-positive evidence74% evidence | 23.1/35 Revenue 100% · PAT 100% · OPM change 1.8 pp 62% evidence | 19.7/25 ROCE 34.3% · OPM 136.8% 76% evidence | 4.5/20 P/E 22.3× · PEG 2.92 65% evidence | 5.3/20 RS sector -19% · RS bench -33.1% · 1Y -0.8%0 of 5 weeks ahead to 2026-07-31 100% evidence | |
| Exact sum: 23.1 + 19.7 + 4.5 + 5.3 = 52.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -19% and the one-year return is -0.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 17OR Royalties Inc.OR | 51.5/100Mixed-positive evidence71% evidence | TURNING | 24.1/35 Revenue 61.7% · PAT 100% · OPM change 15.3 pp 83% evidence | 12.2/25 ROCE 5.9% · OPM 85.4% 76% evidence | 8.8/20 P/E 28.4× · PEG — 15% evidence | 6.4/20 RS sector -9.4% · RS bench -9.3% · 1Y -4.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 24.1 + 12.2 + 8.8 + 6.4 = 51.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -9.4% and the one-year return is -4.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 18Barrick Mining CorporationB | 50.7/100Mixed-positive evidence75% evidence | FADING | 22.8/35 Revenue 49.4% · PAT 100% · OPM change 11.6 pp 95% evidence | 10.6/25 ROCE 5.6% · OPM 50.1% 76% evidence | 10.9/20 P/E 9.5× · PEG — 15% evidence | 6.4/20 RS sector -3.3% · RS bench -3.3% · 1Y 29%4 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 10.6 + 10.9 + 6.4 = 50.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -3.3% and the one-year return is 29%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 19Kinross Gold CorporationKGC | 50.4/100Mixed-positive evidence75% evidence | FADING | 19.8/35 Revenue 39.4% · PAT 98.7% · OPM change 8.2 pp 95% evidence | 14.1/25 ROCE 10.5% · OPM 53% 76% evidence | 11.3/20 P/E 9× · PEG — 15% evidence | 5.2/20 RS sector -8.8% · RS bench -9.1% · 1Y 18.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 14.1 + 11.3 + 5.2 = 50.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Coeur Mining, Inc.CDE | 46.6/100Mixed-negative evidence71% evidence | BREAKING OUT | 23.6/35 Revenue 100% · PAT 100% · OPM change 23.5 pp 83% evidence | 6.1/25 ROCE 3.8% · OPM 40.8% 76% evidence | 9.8/20 P/E 15.5× · PEG — 15% evidence | 7.1/20 RS sector -5.6% · RS bench -5.8% · 1Y 9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 6.1 + 9.8 + 7.1 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Alamos Gold Inc.AGI | 46.5/100Thin evidence · provisional58% evidence | ASLEEP | 20.5/35 Revenue — · PAT — · OPM change 29.4 pp 45% evidence | 12.9/25 ROCE 6.4% · OPM 57.8% 76% evidence | 10.5/20 P/E 11× · PEG — 15% evidence | 2.6/20 RS sector -14.8% · RS bench -15.4% · 1Y 6.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 12.9 + 10.5 + 2.6 = 46.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22Pan American Silver Corp.PAAS | 44.8/100Mixed-negative evidence71% evidence | ASLEEP | 22.6/35 Revenue 33.8% · PAT 100% · OPM change 18.5 pp 83% evidence | 10.1/25 ROCE 7% · OPM 48.1% 76% evidence | 9.5/20 P/E 17.6× · PEG — 15% evidence | 2.6/20 RS sector -10.1% · RS bench -10.7% · 1Y 30.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.6 + 10.1 + 9.5 + 2.6 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Equinox Gold Corp.EQX | 43.2/100Thin evidence · provisional53% evidence | TURNING | 21.0/35 Revenue — · PAT 98.7% · OPM change 48.8 pp 32% evidence | 7.8/25 ROCE 5.3% · OPM 45.3% 76% evidence | 9.4/20 P/E 18.3× · PEG — 15% evidence | 5.0/20 RS sector -15.8% · RS bench -16.4% · 1Y 7.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21 + 7.8 + 9.4 + 5 = 43.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Hycroft Mining Holding CorporationHYMC | 28.7/100Adverse evidence60% evidence | ASLEEP | 13.9/35 Revenue — · PAT — · OPM change 16.9 pp 52% evidence | 3.0/25 ROCE -10.1% · OPM -177.5% 76% evidence | 11.5/20 P/E 3× · PEG — 15% evidence | 0.3/20 RS sector -23.1% · RS bench -26.5% · 1Y 210.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 3 + 11.5 + 0.3 = 28.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Allied Gold CorporationAAUC | 28.3/100Adverse evidence64% evidence | ASLEEP | 10.3/35 Revenue 53% · PAT — · OPM change -9.6 pp 62% evidence | 7.4/25 ROCE 5.9% · OPM 14.7% 76% evidence | 9.7/20 P/E 16.6× · PEG — 15% evidence | 0.9/20 RS sector -20% · RS bench -21% · 1Y 32.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 10.3 + 7.4 + 9.7 + 0.9 = 28.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Gold Fields LimitedGFI | 51.1/100Thin evidence · provisional38% evidence | BREAKING OUT | 18.6/35 Revenue — · PAT — · OPM change — 9% evidence | 15.5/25 ROCE 12.8% · OPM — 46% evidence | 10.2/20 P/E 11.1× · PEG — 15% evidence | 6.8/20 RS sector -9.1% · RS bench -9.4% · 1Y 1.5%5 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 15.5 + 10.2 + 6.8 = 51.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27Seabridge Gold Inc.SA | 32.2/100Thin evidence · provisional50% evidence | ASLEEP | 14.0/35 Revenue — · PAT — · OPM change — 33% evidence | 5.7/25 ROCE -0.4% · OPM — 61% evidence | 8.5/20 P/E 187.5× · PEG — 15% evidence | 4.0/20 RS sector -5.8% · RS bench -5.9% · 1Y 45.1%2 of 12 weeks ahead 100% evidence |
| Exact sum: 14 + 5.7 + 8.5 + 4 = 32.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28NovaGold Resources Inc.NG | 29.8/100Thin evidence · provisional47% evidence | ASLEEP | 13.9/35 Revenue — · PAT — · OPM change — 33% evidence | 5.2/25 ROCE -5.6% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 0.7/20 RS sector -25.2% · RS bench -25.4% · 1Y -7.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 5.2 + 10 + 0.7 = 29.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Franco-Nevada Corporation's stock price today?
Franco-Nevada Corporation trades at $259, +21.3% over the past year. The company is valued at $50.0 B. The stock sits at 77% of its 52-week range of $187–$281, +10.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 7 weeks in. — as of 17 September 2026.
What were Franco-Nevada Corporation's latest quarterly results?
Franco-Nevada Corporation reported revenue of $0.6 B and net profit of $0.3 B for the Jun 26 quarter. Revenue rose 56.8% and profit rose 40.0% year on year. Earnings per share were $1.83. The operating margin was 77.6%, 6.2 pp lower than a year earlier. — as of 17 September 2026.
What is Franco-Nevada Corporation's revenue?
Franco-Nevada Corporation reported revenue of $0.6 B in the Jun 26 quarter, +56.8% year on year. For the full FY25 fiscal year, revenue was $1.8 B (+64.0%). Over the last 4 years revenue compounded at 8.8% a year. — as of 17 September 2026.
What is Franco-Nevada Corporation's profit?
Franco-Nevada Corporation earned $0.3 B of net profit in the Jun 26 quarter, +40.0% year on year — the 6th straight quarter of growth. Full-year FY25 profit was $1.1 B. The operating margin ran 77.6% in the latest quarter. — as of 17 September 2026.
What is Franco-Nevada Corporation's market cap?
Franco-Nevada Corporation's market capitalisation is $50.0 B at a stock price of $259. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.
What is Franco-Nevada Corporation's P/E ratio?
Franco-Nevada Corporation trades at a P/E of 34.0×, at the 29th percentile of its own 5-year range, against a long-run median of 38.9×. This is a comparison with the stock's own history, not a value call — as of 17 September 2026.
Does Franco-Nevada Corporation pay a dividend?
Yes — Franco-Nevada Corporation declared $0.44 per share for Jun 26, and $1.64 per share across the last four reported quarters. — as of 17 September 2026.
What is Franco-Nevada Corporation's dividend per share?
Franco-Nevada Corporation's most recently declared dividend is $0.44 per share for Jun 26, giving $1.64 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 17 September 2026.
What is Franco-Nevada Corporation's dividend yield?
Franco-Nevada Corporation's trailing dividend yield is 0.63%: $1.64 declared per share across the last four reported quarters, against a share price of $259. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 17 September 2026.
Is Franco-Nevada Corporation overvalued?
On its own history, Franco-Nevada Corporation looks cheap: its P/E of 34.0× has been cheaper only 29% of the time in 5 years (long-run median 38.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 17 September 2026.
Is Franco-Nevada Corporation growing?
Yes — Franco-Nevada Corporation is growing: latest-quarter revenue +56.8% year on year, profit +40.0%, and the margin −6.2 pp at 77.6%. The 4-year compound rates are 8.8% (revenue) and 11.0% (profit). The earnings engine currently reads: improving — as of 17 September 2026.
How is Franco-Nevada Corporation performing?
Franco-Nevada Corporation is in a confirmed uptrend, 7 weeks in. Its latest quarter's revenue rose 56.8% and profit rose 40.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 17 September 2026.
What stage is Franco-Nevada Corporation in?
Improving — profit growth bottomed 7 quarters ago at −187.5% and has held its recovery at +87.3%, ROCE lifting at 23.2%. The read comes from the last 12 quarters of growth (revenue growth +73.1% latest, profit growth +87.3% latest, eps growth +88.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 17 September 2026.
Is Franco-Nevada Corporation in an uptrend?
Yes — the price is in a confirmed uptrend (week 7 of stage 2), trading +10.4% versus its 200-day average and at 77% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.
Is Franco-Nevada Corporation beating the market?
On recent form, yes — Franco-Nevada Corporation has been ahead of the S&P 500 on a trailing-13-week view for 5 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved +227% against the S&P 500's +255% — behind the index over the full window. — as of 17 September 2026.
Will Franco-Nevada Corporation's stock price go up?
This page publishes no price forecast for Franco-Nevada Corporation. What it measures instead: the stock price is $259, the price is in a confirmed uptrend 7 weeks in. Its P/E of 34.0× sits at the 29th percentile of its own 5-year range. — as of 17 September 2026.
Is the market betting against Franco-Nevada Corporation?
No — short interest is 1.8% of Franco-Nevada Corporation's tradable float, about 5.3 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.
What is Franco-Nevada Corporation's capex?
Franco-Nevada Corporation spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 17 September 2026.
What is Franco-Nevada Corporation's cash flow?
Franco-Nevada Corporation generated $1.5 B of operating cash flow in FY25 and $1.5 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $1.1 B, so operating cash ran ahead of profit. — as of 17 September 2026.
Is Franco-Nevada Corporation's profit real cash?
Yes — over the last 3 fiscal years, 141% of Franco-Nevada Corporation's reported profit arrived as operating cash. In FY25, operating cash was $1.5 B against reported profit of $1.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 17 September 2026.
How financially safe is Franco-Nevada Corporation?
On the balance sheet, the Z-score reads 38.02 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 17 September 2026.
Where is Franco-Nevada Corporation in its business cycle?
Franco-Nevada Corporation's FY25 operating margin was 74.2%, against a 5-year band of −35.2%–74.2%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 77.6%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.
What could break the Franco-Nevada Corporation story?
The sharpest disagreement: annual EPS moved +100.7% against a +21.3% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.
Is Franco-Nevada Corporation a stock worth studying right now?
This is not investment advice. The machine read: Franco-Nevada Corporation is coiled. The quarters are improving, yet the P/E sits at the 29th percentile of its own 5-year range — the business is moving before the market. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.
Not SEBI Registered !! Not Investment advice !!